Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1 | Scientific Reports – Nature.com

Geretti, A. M. et al. Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health Organization (WHO) clinical characterization protocol (UK): A prospective observational study. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa1605 (2020).

Article PubMed Central Google Scholar

Bhaskaran, K. et al. HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV 8, e24e32 (2021).

Article CAS PubMed Google Scholar

Tesoriero, J. M. et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw. Open 4, e2037069 (2021).

Article PubMed PubMed Central Google Scholar

Recommendations from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID vaccines, third doses and boosters: Update for service users. https://www.bhiva.org/recommendations-from-the-JCVI-on-COVID-vaccines-third-doses-and-boosters. Accessed 17 Dec 2021.

Touizer, E. et al. Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles. iScience 26, 105862 (2023).

Article ADS CAS PubMed Google Scholar

Touizer, E. et al. Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV 8, e317e318 (2021).

Article CAS PubMed PubMed Central Google Scholar

Vergori, A. et al. SARS-CoV-2 omicron variant neutralization after third dose vaccination in PLWH. Viruses 14, 1710 (2022).

Article CAS PubMed PubMed Central Google Scholar

Vergori, A. et al. Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV. Nat. Commun. 13, 4922 (2022).

Article CAS PubMed PubMed Central Google Scholar

Diamond, M. S., Lambris, J. D., Ting, J. P. & Tsang, J. S. Considering innate immune responses in SARS-CoV-2 infection and COVID-19. Nat. Rev. Immunol. 22, 465470 (2022).

Article CAS PubMed PubMed Central Google Scholar

Lee, M. J. & Blish, C. A. Defining the role of natural killer cells in COVID-19. Nat. Immunol. https://doi.org/10.1038/s41590-023-01560-8 (2023).

Article PubMed PubMed Central Google Scholar

Di Vito, C. et al. Natural killer cells in SARS-CoV-2 infection: Pathophysiology and therapeutic implications. Front. Immunol. 13, 888248 (2022).

Article CAS PubMed PubMed Central Google Scholar

Bjrkstrm, N. K., Strunz, B. & Ljunggren, H.-G. Natural killer cells in antiviral immunity. Nat. Rev. Immunol. https://doi.org/10.1038/s41577-021-00558-3 (2021).

Article PubMed PubMed Central Google Scholar

Cox, A. et al. Targeting natural killer cells to enhance vaccine responses. Trends Pharmacol. Sci. 42, 789801 (2021).

Article CAS PubMed PubMed Central Google Scholar

Maucourant, C. et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci. Immunol. 5, eabd6832 (2020).

Article CAS PubMed PubMed Central Google Scholar

Bi, J. NK cell dysfunction in patients with COVID-19. Cell. Mol. Immunol. 19, 127129 (2022).

Article CAS PubMed PubMed Central Google Scholar

Narni-Mancinelli, E. & Vivier, E. Clues that natural killer cells help to control COVID. Nature 600, 226227 (2021).

Article ADS CAS PubMed Google Scholar

Bao, C. et al. Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients. Exp. Hematol. Oncol. 10, 5 (2021).

Article CAS PubMed PubMed Central Google Scholar

Krmer, B. et al. Early IFN- signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity 54, 2650-2669.e14 (2021).

Article PubMed PubMed Central Google Scholar

Witkowski, M. et al. Untimely TGF responses in COVID-19 limit antiviral functions of NK cells. Nature 600, 295301 (2021).

Article ADS CAS PubMed Google Scholar

Kuan Brli, P. & Brizi, I. Taking on SARS-CoV-2. eLife 11, e80552 (2022).

Article PubMed PubMed Central Google Scholar

Hammer, Q. et al. SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells. Cell Rep. 38, 110503 (2022).

Article CAS PubMed PubMed Central Google Scholar

Hagemann, K. et al. Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients. Eur. J. Immunol. 52, 12971307 (2022).

Article CAS PubMed PubMed Central Google Scholar

Tso, F. Y. et al. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma. PloS One 16, e0247640 (2021).

Article CAS PubMed PubMed Central Google Scholar

Fielding, C. A. et al. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies. eLife 11, e74489 (2022).

Article CAS PubMed PubMed Central Google Scholar

Rieke, G. J. et al. Natural killer cell-mediated antibody-dependent cellular cytotoxicity against SARS-CoV-2 after natural infection is more potent than after vaccination. J. Infect. Dis. 225, 16881693 (2022).

Article CAS PubMed Google Scholar

Dufloo, J. et al. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Rep. Med. 2, 100275 (2021).

Article CAS PubMed PubMed Central Google Scholar

Yu, Y. et al. Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients. Signal Transduct. Target. Ther. 6, 110 (2021).

PubMed PubMed Central Google Scholar

Gorman, M. J. et al. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination. Cell Rep. Med. 2, 100405 (2021).

Article CAS PubMed PubMed Central Google Scholar

Mercado, N. B. et al. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature 586, 583588 (2020).

Article ADS CAS PubMed PubMed Central Google Scholar

Yu, J. et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science 369, 806811 (2020).

Article ADS CAS PubMed PubMed Central Google Scholar

Anand, S. P. et al. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. Cell Rep. Med. 2, 100290 (2021).

Article CAS PubMed PubMed Central Google Scholar

Lee, W. S. et al. Decay of Fc-dependent antibody functions after mild to moderate COVID-19. Cell Rep. Med. 2, 100296 (2021).

Article CAS PubMed PubMed Central Google Scholar

Grunst, M. W. & Uchil, P. D. Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2s evasive maneuvering. Cell Rep. Med. 3, 100540 (2022).

Article CAS PubMed PubMed Central Google Scholar

Richardson, S. I. et al. SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity. Cell Rep. Med. 3, 100510 (2022).

Article CAS PubMed PubMed Central Google Scholar

Hensley, K. S. et al. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. PLoS Med. 19, e1003979 (2022).

Article CAS PubMed PubMed Central Google Scholar

Peppa, D. et al. Adaptive reconfiguration of natural killer cells in HIV-1 infection. Front. Immunol. 9, 474 (2018).

Article PubMed PubMed Central Google Scholar

Brunetta, E. et al. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 24, 2734 (2010).

Article PubMed Google Scholar

Gondois-Rey, F. et al. NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147. Clin. Transl. Immunol. 6, e150 (2017).

Article Google Scholar

Zhou, J. et al. An NK cell population lacking FcR is expanded in chronically infected HIV patients. J. Immunol. 194, 46884697 (2015).

Article CAS PubMed Google Scholar

Schlums, H. et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42, 443456 (2015).

Article CAS PubMed PubMed Central Google Scholar

Lee, J. et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 42, 431442 (2015).

Article CAS PubMed PubMed Central Google Scholar

Wang, Y. et al. HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells. Nat. Immunol. 21, 274286 (2020).

Article CAS PubMed PubMed Central Google Scholar

Hammer, Q. et al. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat. Immunol. 19, 453463 (2018).

Article CAS PubMed Google Scholar

Shah, S. V. et al. CMV primes functional alternative signaling in adaptive g NK cells but is subverted by lentivirus infection in rhesus macaques. Cell Rep. 25, 2766-2774.e3 (2018).

Article CAS PubMed PubMed Central Google Scholar

Peppa, D. Natural killer cells in human immunodeficiency virus-1 infection: Spotlight on the impact of human cytomegalovirus. Front. Immunol. 8, 1322 (2017).

Article PubMed PubMed Central Google Scholar

Lanier, L. L., Yu, G. & Phillips, J. H. Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation. J. Immunol. 1950(146), 15711576 (1991).

Article Google Scholar

Liu, W. et al. FcR gene editing reprograms conventional NK cells to display key features of adaptive human NK cells. iScience 23, 101709 (2020).

Article ADS CAS PubMed PubMed Central Google Scholar

Shemesh, A. et al. Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcRI expression. J. Exp. Med. 219, e20220551 (2022).

Article PubMed PubMed Central Google Scholar

Hwang, I. et al. Identification of human NK cells that are deficient for signaling adaptor FcR and specialized for antibody-dependent immune functions. Int. Immunol. 24, 793802 (2012).

Article CAS PubMed PubMed Central Google Scholar

Baslio-Queirs, D. et al. Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assays. Bone Marrow Transpl. 57, 712720 (2022).

Article Google Scholar

Duhan, V. et al. NK cell-intrinsic FcRI limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection. PLoS Pathog. 15, e1007797 (2019).

Go here to see the original:

Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1 | Scientific Reports - Nature.com